Exane Derivatives’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-604
| Closed | -$14.5K | – | 1026 |
|
|
2021
Q2 | $14.5K | Buy |
+604
| New | +$14.5K | ﹤0.01% | 719 |
|
|
2021
Q1 | – | Sell |
-5,505
| Closed | -$294K | – | 861 |
|
|
2020
Q4 | $294K | Buy |
5,505
+2,580
| +88% | +$138K | 0.09% | 241 |
|
|
2020
Q3 | $121K | Sell |
2,925
-1,066
| -27% | -$44K | 0.03% | 262 |
|
|
2020
Q2 | $193K | Sell |
3,991
-727
| -15% | -$35.2K | 0.05% | 200 |
|
|
2020
Q1 | $199K | Buy |
+4,718
| New | +$199K | 0.06% | 184 |
|